The HbA1c (mean ± SD) levels were almost comparable between before and in the first and second year of the pandemic [7.27 ± 0.97% (55.9 ± 10.6 mmol/mol) in 2019; 7.28 ± 0.92% (56.1 ± 10.2 mmol/mol) in 2020; 7.25 ± 0.94% (55.7 ± 10.2 mmol/mol) in 2021, respectively] in the whole population (Figure 2a ); the difference in HbA1c among the 3 years did not reach statistical significance.
← all excerpts
Impact of COVID-19 pandemic on behavioral changes and glycemic control and a survey of telemedicine in patients with diabetes: A multicenter retrospective observational study.
1
—
—